Stay updated with breaking news from Research Models. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Charles River Laboratories International Inc (NYSE: CRL) reported third-quarter (Q3) sales of $1.03 billion, an increase of 3.8% Y/Y, beating the
Envestnet Asset Management Inc. lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 8.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 179,954 shares of the medical research company’s stock after purchasing an additional 13,741 shares during […]
Revenue Growth Amidst Challenges, Non-GAAP Earnings Per Share Rise
Banco Bilbao Vizcaya Argentaria S.A. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,442 shares of the medical research company’s stock after selling 109 shares […]
Vestmark Advisory Solutions Inc. increased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.9% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 38,370 shares of the medical research company’s stock after purchasing an additional 1,434 shares […]